Clinical presentation of a group of NF2 patients to a tertiary referral skull base unit

British Journal of Neurosurgery

Volumn 14, Issue 2, 2000, Pages 101-104

  Da Cruz, Melville J ^a,b   Hardy, D G ^a   Moffat, D A ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Neurofibromatos 2; Presentation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CLINICAL FEATURE; FEMALE; HUMAN; HYPOACUSIS; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD TUMOR; VESTIBULAR DISORDER;

EID: 0034019223     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690050004507     Document Type: Article

References (18)

1. 1 Rouleau GA, Wertelecki W, Haines JL, et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987;329:246-8.
2. 2 Seizinger BR, Rouleau G, Ozelius LJ, et al. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science 1987;236:317-19.
3. 3 Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45:575-8.
4. 4 Mulvihill JJ, Parry DM, Sherman JL, et al. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 1990;113:39-52.
5. 5 Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84:603-18.
6. 6 Mayfrank L, Wullich B, Wolff G, et al. Neurofibromatosis 2: a clinically and genetically heterogeneous disease? Report on 10 sporadic cases. Clin Genet 1990;38:362-70.
7. 7 Baldwin D, King TT, Chevretton E, et al. Bilateral cerebellopontine angle tumors in neurofibromatosis type 2. J Neurosurg 1991;74:910-15.
8. 8 Doyle KJ, Shelton C. Hearing preservation in bilateral acoustic neuroma surgery. Am J Otol 1993;14:562-5.
9. 9 Akeson P, Holtas S. Radiological investigation of neurofibromatosis type 2. Neuroradiology 1994;36:107-10.
10. 10 Abaza MM, Makariou E, Armstrong M, et al. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 1996;106:694-9.
11. 11 Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 1981;29:57-65.
12. 12 Huson SM, Thrush DC. Central neurofibromatosis. Q J Med 1985;55:213-24.
13. 13 Tos M, Thomsen J. Epidemiology of acoustic neuromas. J Laryngol Otol 1984;98:685-92.
14. 14 Nestor JJ, Korol HW, Nutik SL, et al. The incidence of acoustic neuromas [letter]. Arch Otolaryngol Head Neck Surg 1988;114:680.
15. 15 Selesnick SH, Jackler RK. Clinical manifestations and audiologic diagnosis of acoustic neuromas. Otolaryngol Clin North Am 1992;25:521-51.
16. 16 Glasscock ME, 3d, Hart MJ, Vrabec JT. Management of bilateral acoustic neuroma. Otolaryngol Clin N Am 1992;25:449-69.
17. 17 Briggs RJ, Brackmann DE, Baser ME, et al. Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 1994;120:1307-14.
18. 18 Evans DG, Ramsden R, Huson SM, et al. Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol 1993;107:401-6.